Propylthiouracil Tablet
NDC Package 0480-9242-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Propylthiouracil tablets is propylthiouracil is used to treat overactive thyroid (hyperthyroidism). This formulation utilizes a tablet delivery system. Marketed by Teva Pharmaceuticals, Inc., this product is identified by NDC 0480-9242 and is authorized under FDA application ANDA080172.

Identification & Billing

NDC Package Code
0480-9242-01
Package Description
100 TABLET in 1 BOTTLE
Product Code
11-Digit Billing Format
00480924201
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
100 EA
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Propylthiouracil
Non-Proprietary Name
Propylthiouracil
Substance Name
Propylthiouracil
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Usage Information
Propylthiouracil is used to treat overactive thyroid (hyperthyroidism). It works by stopping the thyroid gland from making too much thyroid hormone. This medication is not recommended for use in children.

Regulatory & Marketing

Labeler Name
Teva Pharmaceuticals, Inc.
Product Type
Human Prescription Drug
FDA Application #
ANDA080172
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
07-10-2024
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (0480-9242). Click a package code to view its specific billing and regulatory data.

52630 TABLET in 1 BOX
63156 TABLET in 1 CONTAINER

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0480-9242-01 identifies a specific commercial package of 100 tablet in 1 bottle of Propylthiouracil, a human prescription drug labeled by Teva Pharmaceuticals, Inc.. This tablet is formulated for oral use and contains propylthiouracil as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Teva Pharmaceuticals, Inc. on July 10, 2024. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

Propylthiouracil is used to treat overactive thyroid (hyperthyroidism). It works by stopping the thyroid gland from making too much thyroid hormone. This medication is not recommended for use in children.

How is this Teva Pharmaceuticals, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00480924201. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0480-9242-01
11-Digit CMS (5-4-2)
00480-9242-01

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.